Recent Finacing
Recent Raise
Step Pharma is a French biotech developing dencatistat, a highly selective CTPS1 inhibitor that targets CTPS2-null cancers through a synthetic-lethal precision-oncology approach.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Step Pharma.
